[3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain
- PMID: 7119802
- DOI: 10.1111/j.1471-4159.1982.tb12579.x
[3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain
Abstract
The binding of [3H]dopamine to brain regions of calf, rat, and human was investigated. The calf caudate contained the highest density of [3H]dopamine binding sites, with a Bmax value of 185 fmol/mg protein, whereas rat and human striatum contained one-third this number of sites. The KD values for [3H]dopamine in all tissues were 2-3 nM. Dopaminergic catecholamines (dopamine, apomorphine, 6,7-dihydroxy-2-aminotetralin, and N-propylnorapomorphine) inhibited the binding of [3H]dopamine in all three species, at low concentrations, with IC50 values of 1.5 to 6 nM. Neuroleptics, in contrast, inhibited the binding at high concentrations (with IC50 values of 200 to 40,000 nM). The [3H]dopamine binding sites were saturable, heat-labile, and detectable only in dopamine-rich brain regions; these sites differed from D2 dopamine sites (labeled by [3H]butyrophenone neuroleptics), and from D1 dopamine sites (labeled by [3H]thioxanthene neuroleptics) associated with the dopamine-stimulated adenylate cyclase. We have, therefore, called these high-affinity [3H]dopamine binding sites D3 sites. [3H]Apomorphine and [3H]ADTN also appeared to label D3 sites. These ligands however, were less selective than [3H]dopamine, and labeled sites other than D3 as well. Assay conditions were important in determining the parameters of [3H]dopamine binding. The optimum conditions for selective labeling of the D3 dopaminergic sites, using [3H]dopamine, required the presence of EDTA and ascorbate.
Similar articles
-
Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.J Neurosci. 1982 Jul;2(7):895-906. doi: 10.1523/JNEUROSCI.02-07-00895.1982. J Neurosci. 1982. PMID: 6124583 Free PMC article.
-
Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors.Eur J Pharmacol. 1979 Apr 15;55(2):137-42. doi: 10.1016/0014-2999(79)90385-6. Eur J Pharmacol. 1979. PMID: 456412
-
Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.J Neurochem. 1986 Apr;46(4):1058-67. doi: 10.1111/j.1471-4159.1986.tb00618.x. J Neurochem. 1986. PMID: 2936868
-
Properties of dopamine agonist and antagonist binding sites in mammalian retina.Brain Res. 1980 Aug 4;194(2):403-18. doi: 10.1016/0006-8993(80)91221-4. Brain Res. 1980. PMID: 6770965
-
Dopaminergic 3H-agonist receptors in rat brain. New evidence on localization and pharmacology.Life Sci. 1984 Jan 23;34(4):307-15. doi: 10.1016/0024-3205(84)90617-9. Life Sci. 1984. PMID: 6363861 Review.
Cited by
-
Knocking out the dopamine reuptake transporter (DAT) does not change the baseline brain arachidonic acid signal in the mouse.Int J Neurosci. 2012 Jul;122(7):373-80. doi: 10.3109/00207454.2012.665972. Epub 2012 Mar 26. Int J Neurosci. 2012. PMID: 22376027 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources